DE:TEHP's free cash flow for Q2 2024 was $-1.22M. For the 2024 fiscal year, DE:TEHP's free cash flow was decreased by $-43.58M and operating cash flow was $6.10M. See a summary of the company’s cash flow.

Cash Flow	TTM	Apr 23	Apr 22	Apr 21	Apr 20	Apr 19
Operating Cash Flow	$ 8.62M	$ -12.89M	$ 9.46M	$ 31.18M	$ 5.83M	$ -11.60M
Investing Cash Flow	$ -46.31M	$ -77.64M	$ -56.41M	$ -9.86M	$ -3.81M	$ 4.54M
Financing Cash Flow	$ 8.85M	$ 2.90M	$ 3.20M	$ 112.33M	$ 1.10M	$ -2.86M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 95.56M	$ 38.89M	$ 126.52M	$ 170.26M	$ 36.61M	$ 33.50M
Income Tax Paid Supplemental Data	$ 54.00K	$ 260.00K	$ 64.00K	-	-	-
Interest Paid Supplemental Data	$ 1.12M	$ 1.12M	$ 1.67M	$ 5.00K	$ 8.00K	$ 11.00K
Issuance Of Capital Stock	-	-	-	$ 32.14M	$ 0.00	$ 258.00K
Issuance Of Debt	$ -391.00K	$ -505.00K	$ -162.00K	$ 138.46M	$ 0.00	-
Repayment Of Debt	$ -391.00K	$ -505.00K	$ -162.00K	$ -93.00K	$ -78.00K	$ -74.00K
Free Cash Flow	$ -37.69M	$ -90.53M	$ -46.95M	$ 21.32M	$ 2.02M	$ -13.10M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Avid Bioservices Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing